Evidence map›Paper›PMID 30793795›Full record

ArticleStatistics in medicine2019

Correlation-adjusted regression survival scores for high-dimensional variable selection.

Thomas Welchowski, Verena Zuber, Matthias Schmid

Open access · hybridAbstract read
In one paragraph

Article in Statistics in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thomas WelchowskiDepartment of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-2940-647X
Verena ZuberMRC Biostatistics Unit, Cambridge University, Cambridgeshire, UK.
Matthias SchmidDepartment of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0002-0788-0317
University Hospital Bonn · DEUniversity of Cambridge · GB

Funding

Medical Research Council MC_UU_00002/7Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

backgroundThe development of classification methods for personalized medicine is highly dependent on the identification of predictive genetic markers. In survival analysis, it is often necessary to discriminate between influential and noninfluential markers. It is common to perform univariate screening using Cox scores, which quantify the associations between survival and each of the markers to provide a ranking. Since Cox scores do not account for dependencies between the markers, their use is suboptimal in the presence of highly correlated markers.

methodsAs an alternative to the Cox score, we propose the correlation-adjusted regression survival (CARS) score for right-censored survival outcomes. By removing the correlations between the markers, the CARS score quantifies the associations between the outcome and the set of "decorrelated" marker values. Estimation of the scores is based on inverse probability weighting, which is applied to log-transformed event times. For high-dimensional data, estimation is based on shrinkage techniques.

resultsThe consistency of the CARS score is proven under mild regularity conditions. In simulations with high correlations, survival models based on CARS score rankings achieved higher areas under the precision-recall curve than competing methods. Two example applications on prostate and breast cancer confirmed these results. CARS scores are implemented in the R package carSurv.

conclusionsIn research applications involving high-dimensional genetic data, the use of CARS scores for marker selection is a favorable alternative to Cox scores even when correlations between covariates are low. Having a straightforward interpretation and low computational requirements, CARS scores are an easy-to-use screening tool in personalized medicine research.

Indexed as

Survival AnalysisAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsComputer SimulationFemaleGenetic MarkersHumansMaleMiddle AgedProportional Hazards ModelsProstatic NeoplasmsRegression AnalysisWatchful WaitingBiomarkers, TumorGenetic Markersbiomarker discoverybreast cancermultigene signaturepersonalized medicineprostate cancersurvival modeling

Identifiers

PMID30793795
PMCPMC6519238
OpenAlexW2791110929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.